Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 114.30
-0.60 (-0.52%)
At close: Jul 6, 2026
Beacon Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 1,457 | 946.51 | 521.01 | 509.84 | 935.04 | 863.17 |
Depreciation & Amortization | 582.6 | 631.4 | 527.78 | 518.92 | 439.7 | 385.16 |
Loss (Gain) From Sale of Assets | -0.17 | 0.01 | 6.5 | -3.07 | - | - |
Other Operating Activities | 325.31 | 153.83 | 287.23 | -147.1 | 438.72 | 75.87 |
Change in Accounts Receivable | -853.43 | -50.52 | -767.59 | -251.01 | -30.72 | -873.78 |
Change in Inventory | -879.48 | -435.6 | -895.97 | -19.73 | -693.28 | -246.07 |
Change in Accounts Payable | 207.39 | -236.31 | 680.87 | 191.87 | -7.83 | 183.53 |
Change in Income Taxes | - | - | - | - | -169.84 | 162.23 |
Change in Other Net Operating Assets | 1,686 | 590.71 | -539.46 | -178.55 | 170.39 | -353.56 |
Operating Cash Flow | 2,525 | 1,600 | -179.63 | 621.18 | 1,082 | 196.56 |
Operating Cash Flow Growth | -9.35% | - | - | -42.60% | 450.56% | -32.49% |
Capital Expenditures | -1,029 | -821.53 | -1,095 | -1,814 | -1,719 | -313.41 |
Sale of Property, Plant & Equipment | 0.82 | 0.24 | 30.15 | - | - | - |
Sale (Purchase) of Intangibles | -3 | -1.2 | -25.22 | - | - | - |
Investment in Securities | -96.39 | -194.48 | -1,276 | -2,190 | -118.52 | -403.71 |
Other Investing Activities | -31.86 | - | -0 | 39.83 | - | 3.24 |
Investing Cash Flow | -1,160 | -1,017 | -2,366 | -3,965 | -1,838 | -713.87 |
Short-Term Debt Issued | - | - | - | - | 1,529 | 349.06 |
Long-Term Debt Issued | - | - | 2,864 | 3,628 | - | - |
Total Debt Issued | - | - | 2,864 | 3,628 | 1,529 | 349.06 |
Long-Term Debt Repaid | - | -241.8 | - | - | -199.71 | -33.27 |
Total Debt Repaid | -948.32 | -241.8 | - | - | -199.71 | -33.27 |
Net Debt Issued (Repaid) | -948.32 | -241.8 | 2,864 | 3,628 | 1,330 | 315.79 |
Common Dividends Paid | -268.91 | -347.11 | -369.56 | -371.06 | -373.53 | -59.42 |
Financing Cash Flow | -1,217 | -588.9 | 2,494 | 3,257 | 956.25 | 256.37 |
Foreign Exchange Rate Adjustments | -15.12 | -73.24 | -93.69 | - | - | - |
Net Cash Flow | 132.78 | -79.09 | -145.24 | -86.31 | 200.66 | -260.94 |
Free Cash Flow | 1,496 | 778.5 | -1,275 | -1,193 | -637.07 | -116.85 |
Free Cash Flow Margin | 9.61% | 6.21% | -11.91% | -14.02% | -7.94% | -1.64% |
Free Cash Flow Per Share | 6.47 | 3.37 | -5.52 | -5.17 | -2.76 | -0.51 |
Cash Interest Paid | 1,140 | 1,327 | 983.91 | 464.36 | 339.38 | 166.8 |
Cash Income Tax Paid | 418.8 | 255.15 | 257.56 | 271.77 | 450.75 | 17.31 |
Levered Free Cash Flow | - | -8.61 | -3,111 | -3,814 | -1,146 | -562.04 |
Unlevered Free Cash Flow | - | 809.17 | -2,484 | -3,526 | -934.37 | -459.03 |
Change in Working Capital | 160.08 | -131.72 | -1,522 | -257.42 | -731.28 | -1,128 |